Normal view MARC view ISBD view

Prevention of Bone Metastases [electronic resource] /edited by Markus Joerger, Michael Gnant.

by Joerger, Markus [editor.]; Gnant, Michael [editor.]; SpringerLink (Online service).
Material type: materialTypeLabelBookSeries: Recent Results in Cancer Research: 192Publisher: Berlin, Heidelberg : Springer Berlin Heidelberg, 2012.Description: X, 234 p. online resource.ISBN: 9783642218927.Subject(s): Medicine | Oncology | Cancer -- Surgery | Medicine & Public Health | Oncology | Surgical OncologyDDC classification: 616.994 Online resources: Click here to access online In: Springer eBooksSummary: Bone metastases continue to be a major cause of morbidity in cancer patients, but improved understanding of the biology of bone metastases has led to the identification of drugs that are of potential value in not only their treatment but also their prevention. This book, written by recognized experts in the field, provides a detailed overview of current knowledge on this subject. One important focus of the book is the efficacy of bisphosphonates in preventing bone metastases in patients with breast, lung, and prostate cancer and disease progression in cases of multiple myeloma.  The combined use of bisphosphonates and cytostatics is also discussed, with a report on first clinical data.  Further topics addressed include the significance of the bone microenvironment, special issues in the elderly patient, the use of bone turnover markers, and initial findings obtained with denosumab.
Tags from this library: No tags from this library for this title. Add tag(s)
Log in to add tags.
    average rating: 0.0 (0 votes)

Bone metastases continue to be a major cause of morbidity in cancer patients, but improved understanding of the biology of bone metastases has led to the identification of drugs that are of potential value in not only their treatment but also their prevention. This book, written by recognized experts in the field, provides a detailed overview of current knowledge on this subject. One important focus of the book is the efficacy of bisphosphonates in preventing bone metastases in patients with breast, lung, and prostate cancer and disease progression in cases of multiple myeloma.  The combined use of bisphosphonates and cytostatics is also discussed, with a report on first clinical data.  Further topics addressed include the significance of the bone microenvironment, special issues in the elderly patient, the use of bone turnover markers, and initial findings obtained with denosumab.

There are no comments for this item.

Log in to your account to post a comment.
@ Jomo Kenyatta University Of Agriculture and Technology Library

Powered by Koha